Allspring Global Investments’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,362
| Closed | -$16.3K | – | 2328 |
|
|
2023
Q4 | $16.3K | Buy |
+4,362
| New | +$16.3K | ﹤0.01% | 1973 |
|
|
2023
Q3 | – | Sell |
-3,322
| Closed | -$15.8K | – | 2813 |
|
|
2023
Q2 | $15.8K | Buy |
3,322
+1,709
| +106% | +$8.13K | ﹤0.01% | 2486 |
|
|
2023
Q1 | $9.19K | Sell |
1,613
-38,447
| -96% | -$219K | ﹤0.01% | 2596 |
|
|
2022
Q4 | $404K | Sell |
40,060
-208,559
| -84% | -$2.1M | ﹤0.01% | 1651 |
|
|
2022
Q3 | $5.57M | Buy |
248,619
+30,317
| +14% | +$679K | 0.01% | 949 |
|
|
2022
Q2 | $5.41M | Sell |
218,302
-22,025
| -9% | -$546K | 0.01% | 965 |
|
|
2022
Q1 | $9.32M | Sell |
240,327
-3,520
| -1% | -$136K | 0.01% | 904 |
|
|
2021
Q4 | $14.3M | Buy |
+243,847
| New | +$14.3M | 0.02% | 815 |
|